Iradimed (IRMD) EBT (2013 - 2026)

Iradimed (IRMD) has 14 years of EBT data on file, last reported at $7.8 million in Q1 2026.

• EBT for Q1 2026 came in at $7.8 million, up 30.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (up 20.85% YoY), and the FY2025 annual result was $28.4 million, up 16.83% from the prior year.
• EBT steadied at $7.8 million in Q1 2026 per IRMD's latest filing, from $7.8 million in the prior quarter.
• Over five years, EBT peaked at $7.8 million in Q4 2025 and troughed at $3.1 million in Q1 2022.
• A 5-year average of $5.8 million and a median of $5.9 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2024: EBT surged 125.03% in 2022, then grew 0.15% in 2024.
• A 5-year view of EBT shows it stood at $4.7 million in 2022, then grew by 20.79% to $5.7 million in 2023, then advanced by 11.66% to $6.3 million in 2024, then rose by 22.8% to $7.8 million in 2025, then decreased by 0.28% to $7.8 million in 2026.
• Business Quant data shows IRMD's EBT at $7.8 million in Q1 2026, $7.8 million in Q4 2025, and $7.3 million in Q3 2025.